Stay in the know this flea and tick season. Purchase Pet Medications in the U.S., 4th Edition and save 10% through June 3 with promo code PFSAPD2016.
May 10 - Flea and tick products have undergone an upheaval of sorts in recent years. The latest trend has been prescription chewables, now becoming a favorite among veterinarians and pet owners alike, as they are considered easier to administer than topicals. Merial introduced Nexgard in late 2013, and it has since driven Merial’s growth, becoming the company’s third largest product in 2015. Nexgard is picking up the slack from the Frontline family of topical flea & tick products, which went off patent and has been trying to defend its market share against an onslaught of generics.
Also new in the chewable flea and tick world is Merck’s Bravecto. Merck said Bravecto was accounting for the majority of growth in its animal health division (along with swine products). Now in on the action is a new chewable from Zoetis - Simparica - which received FDA approval last month. Next on the U.S. horizon could chewables that combine flea/tick and heartworm control. Merial launched one - Nexgard Spectra - in Europe in 2015. Zoetis is also said to be working on such a solution, but it’s still a couple of years away.
Get the lowdown on the industry in Packaged Facts’ report: Pet Medications in the U.S., 4th Edition.
-- By George Puro